More research is necessary on the modifiable predictors of a sedentary lifestyle in COPD patients. Structured exercise programs and pulmonary rehabilitation have shown important results for ...

Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with type 2 ...

Malnutrition is common in older patients with COPD, who also experience high rates ... rehabilitation education and pulmonary function exercises, as well as the use of medications to improve ...

Researchers from Teesside University and the National Institute for Health and Care Research (NIHR) Applied Research ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

It is clinically relevant among patients with COPD and may lead to dyspnea, impaired exercise tolerance, increased hospitalizations, respiratory failure, and increased mortality. Hyperinflation in ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD ... for all patients or all specific uses.

More than 200 bed days were saved in first few months of a Galway hospitals initiative, which allows patients to be treated ...

The study saw 135 COPD patients with chronic bronchitis receive either 600 mg of tozorakimab or placebo every four weeks for 12 weeks. The trial missed the primary endpoint of demonstrating an ...

Retired fire captain Shawn M. Graves celebrates the 8-year anniversary of his life-saving double lung transplant at ...

Dupixent becomes the first-ever targeted therapy for patients with COPD, the first biologic for the disease, and the first new treatment approach in Europe in over a decade. It has been cleared ...